MindBio Therapeutics Corp. (CSE:MBIO)
Canada · Delayed Price · Currency is CAD 1.100
-0.050 (-4.35%)
Apr 10, 2026, 3:58 PM EST
MindBio Therapeutics Market Cap
MindBio Therapeutics has a market cap or net worth of CAD 8.01 million as of April 10, 2026. Its market cap has increased by 180.20% in one year.
Market Cap
8.01M
Enterprise Value
9.62M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
1.10
Market Cap Chart
Since May 5, 2023, MindBio Therapeutics's market cap has decreased from 79.83M to 8.01M, a decrease of -89.96%. That is a compound annual growth rate of -54.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 10, 2026 | 8.01M | 33.68% |
| Dec 31, 2025 | 5.99M | 109.60% |
| Dec 31, 2024 | 2.86M | -14.04% |
| Dec 27, 2023 | 3.33M | -95.83% |
| May 5, 2023 | 79.83M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PreveCeutical Medical | 11.96M |
| Pharmala Biotech Holdings | 10.89M |
| Glow Lifetech | 9.61M |
| Innovotech | 9.53M |
| COSCIENS Biopharma | 9.01M |
| Marvel Biosciences | 8.82M |
| Aptose Biosciences | 6.13M |
| PharmaTher Holdings | 5.92M |